Although humanized NSG mice used in this study exhibit a functionally validated surrogate human immune system71, this model supports the growth of human cancer cell line and PDXs even when they are not specifically HLA matched to the human CD34+ HSC used for immune reconstitution72. This evidence concerns the gene CD34 and cancer.